Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Pegylated Interferon Alfa-2A for Brain Metastasis from Breast Cancer
NCT00227656Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2005
- Primary completion
- Nov 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2005; status: terminated.
02
Drugs
peginterferon alfa-2a
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00227656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227656.